XANO Industri (XANO) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
5 Jun, 2025Executive summary
Revenue increased by 8% year-over-year to 893 MSEK, driven by acquisitions and modest organic growth.
Operating profit rose 164% to 83 MSEK, with margin improvement to 9.3% from 3.8% year-over-year.
All three business units reported growth and significantly higher results compared to Q1 2024.
Market conditions stabilized, with some recovery in select niches and increased optimism in defense and medtech.
Financial highlights
Net income for the quarter was 48 MSEK, up from 13 MSEK year-over-year.
EPS increased to 0.81 SEK from 0.22 SEK year-over-year.
Cash flow from operations was 18 MSEK, compared to 23 MSEK in Q1 2024.
Solid equity ratio at 46% (43% in Q1 2024).
No non-recurring items affected the period's results.
Outlook and guidance
Cautious stance remains in key customer segments, but general sentiment is more optimistic.
Uncertainty from US trade policy and global geopolitical tensions may impact future performance.
Continued focus on leveraging restructuring and cost-saving measures for further efficiency.
Latest events from XANO Industri
- Profitability and cash flow surged despite mixed segment trends; dividend proposed.XANO
Q4 20255 Feb 2026 - Strong Q3 profit and margin gains, robust cash flow, and continued growth in key sectors.XANO
Q3 202530 Oct 2025 - Profitability and cash flow surged, with strong margins and new orders supporting future growth.XANO
Q2 202510 Jul 2025 - Earnings and margins fell significantly amid weak markets, but strategic actions support future growth.XANO
Q3 202413 Jun 2025 - Sales and earnings fell sharply in H1 2024, with continued market uncertainty and margin pressure.XANO
Q2 202413 Jun 2025 - Earnings and margins fell in 2024, but Q4 improved and strategic acquisitions were completed.XANO
Q4 20245 Jun 2025